DK131576C - Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner - Google Patents

Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner

Info

Publication number
DK131576C
DK131576C DK527668A DK527668A DK131576C DK 131576 C DK131576 C DK 131576C DK 527668 A DK527668 A DK 527668A DK 527668 A DK527668 A DK 527668A DK 131576 C DK131576 C DK 131576C
Authority
DK
Denmark
Prior art keywords
androstanes
oxa
halogen
substituted
preparing
Prior art date
Application number
DK527668A
Other languages
English (en)
Other versions
DK131576B (da
Inventor
M R Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK131576B publication Critical patent/DK131576B/da
Application granted granted Critical
Publication of DK131576C publication Critical patent/DK131576C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11BINFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK527668A 1967-11-03 1968-10-30 Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner DK131576C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (2)

Publication Number Publication Date
DK131576B DK131576B (da) 1975-08-04
DK131576C true DK131576C (da) 1976-01-05

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK527668A DK131576C (da) 1967-11-03 1968-10-30 Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner

Country Status (14)

Country Link
AT (2) AT287932B (da)
BE (1) BE723189A (da)
BR (1) BR6803654D0 (da)
CH (1) CH505855A (da)
DK (1) DK131576C (da)
ES (1) ES359842A1 (da)
FI (1) FI48098C (da)
FR (2) FR1605466A (da)
GB (1) GB1247022A (da)
IE (1) IE33567B1 (da)
IL (1) IL30879A (da)
NL (1) NL6815623A (da)
NO (1) NO132101C (da)
SE (1) SE352360B (da)

Also Published As

Publication number Publication date
SE352360B (da) 1972-12-27
AT287932B (de) 1971-02-10
FR8435M (da) 1971-07-15
FI48098B (da) 1974-02-28
IL30879A (en) 1972-11-28
NL6815623A (da) 1969-05-06
IE33567B1 (en) 1974-08-21
DE1805857A1 (de) 1969-06-26
AT297236B (de) 1972-03-10
NO132101B (da) 1975-06-09
IE33567L (en) 1969-05-03
NO132101C (da) 1975-09-17
GB1247022A (en) 1971-09-22
ES359842A1 (es) 1970-06-16
BR6803654D0 (pt) 1973-01-16
IL30879A0 (en) 1968-12-26
CH505855A (de) 1971-04-15
DE1805857B2 (de) 1977-06-23
FI48098C (fi) 1974-06-10
BE723189A (da) 1969-04-30
DK131576B (da) 1975-08-04
FR1605466A (da) 1976-05-14

Similar Documents

Publication Publication Date Title
DK137232B (da) Analogifremgangsmåde til fremstilling af phenylethanolaminer.
DK122222B (da) Fremgangsmåde til fremstilling af alk-3-en-1-oler.
DK133783B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxy-1-thio-alfa-D-galacto-octopyranosider.
DK120698B (da) Analogifremgangsmåde til fremstilling af acetylguanidiner.
DK124080B (da) Fremgangsmåde til fremstilling af D-6-metyl-8-cyanmetylergolin.
DK121454B (da) Fremgangsmåde til fremstilling af en hjælpestofholdig vaccine.
DK119111B (da) Fremgangsmåde til fremstilling af oxazolidinonderivater.
DK131936C (da) Analogifremgangsmade til fremstilling af 5-phenyl-1h-1,5-benzodiazepin-2,4-dioner
DK118081B (da) Fremgangsmåde til fremstilling af isoksazolderivater.
DK119307B (da) Fremgangsmåde til fremstilling af ketonitriler.
DK122758B (da) Fremgangsmåde til fremstilling af α-methyl-multicyclo-methylaminer.
DK115766B (da) Analogifremgangsmåde til fremstilling af thiocarbamidderivater.
DK131821C (da) Analogifremgangsmade til fremstilling af en 2-karbalkoksyaminobenzimidazol
DK122522B (da) Fremgangsmåde til fremstilling af dichlorquinoliner.
DK123100B (da) Fremgangsmåde til fremstilling af N-tritylimidazoler.
DK119663B (da) Analogifremgangsmåde til fremstilling af 2-benzolsulfonamidopyrimidinforbindelser.
DK118507B (da) Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater.
DK120598B (da) Analogifremgangsmåde til fremstilling af furazanderivater.
DK135287B (da) Analogifremgangsmåde til fremstilling af styrylthiazoliumsalte.
DK131576C (da) Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner
DK125285B (da) Analogifremgangsmåde til fremstilling af furazanderivater.
DK119402B (da) Fremgangsmaade til fremstilling af forgrenede tetrafluorethylenoligomere
DK119976B (da) Analogifremgangsmåde til fremstilling af 18-methyl-19-nor-17α-hydroxyprogesteroner og -17-estere deraf.
DK131994C (da) Analogifremgangsmade til fremstilling af 6alfa,9alfa-difluorprednisolon 17,21-diestere
DK122666B (da) Analogifremgangsmåde til fremstilling af hydrocortison-17-cyclopentancorboxylat.